Table 1.
Demographical and clinical parameters of the study subjects.
| AAA (n = 488) |
Controls (n = 184) |
p-Value | |
|---|---|---|---|
| Age | 70.0 ± 2.8 | 69.6 ± 2.9 | 0.411 |
| Sex, n (%) male | 488 (100) | 184 (100) | - |
| BMI, kg/cm2 | 27.4 ± 3.6 | 26.3 ± 3.3 | 0.021 |
| ABI | 0.9 ± 0.2 | 1.1 ± 0.1 | 0.004 |
| Aortic size, mm | 40.9 ± 11.8 | 18.2 ± 2.8 | <0.001 |
| PAD, n (%) | 122 (25.2) | 5 (2.7%) | <0.001 |
| hsCRP, mg/L ‡ | 3.00 (1.60–6.30) | 1.60 (0.90–3.75) | <0.001 |
| Lipid profiles, mmol/L | |||
| Total-cholesterol | 4.88 ± 0.91 | 4.84 ± 1.14 | 0.592 |
| HDL-cholesterol | 1.17 ± 0.41 | 1.33 ± 0.45 | <0.001 |
| ApoAI | 1.58 ± 0.29 | 1.72 ± 0.32 | <0.001 |
| CV risk factors | |||
| Current smoking, n (%) | 207 (42.4) | 34 (18.5) | <0.001 |
| Hypertension, n (%) | 265 (54.4) | 82 (45.3) | 0.036 |
| Systolic blood pressure, mm Hg | 155.4 ± 21.5 | 147.4 ± 19.2 | 0.021 |
| Diabetes, n (%) | 57 (11.7) | 28 (15.3) | 0.209 |
| Treatments, n(%) | |||
| Use of statins | 250 (51.9) | 67 (36.4) | <0.001 |
| Use of low-dose aspirin | 228 (47.2) | 46 (25.0) | <0.001 |
| Use of b-blockers | 139 (29.1) | 40 (21.6) | 0.051 |